|
TMEM106A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.98989999999589E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.23260000000214E-05 |
| Normal-vs-Stage2 |
5.027500E-04 |
| Normal-vs-Stage3 |
1.374170E-04 |
| Normal-vs-Stage4 |
2.16309999999664E-05 |
| Stage1-vs-Stage2 |
3.268000E-01 |
| Stage1-vs-Stage3 |
8.196400E-01 |
| Stage1-vs-Stage4 |
1.618810E-01 |
| Stage2-vs-Stage3 |
5.547000E-01 |
| Stage2-vs-Stage4 |
1.250580E-01 |
| Stage3-vs-Stage4 |
1.752780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.411140E-04 |
| Normal-vs-AfricanAmerican |
3.82509999999892E-05 |
| Normal-vs-Asian |
1.599760E-03 |
| Caucasian-vs-AfricanAmerican |
4.800300E-02 |
| Caucasian-vs-Asian |
6.125200E-01 |
| AfricanAmerican-vs-Asian |
8.555200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.79599999999525E-05 |
| Normal-vs-Female |
1.352620E-04 |
| Male-vs-Female |
8.220800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.021700E-04 |
| Normal-vs-Extreme_Weight |
5.70819999999861E-05 |
| Normal-vs-Obese |
1.158680E-04 |
| Normal-vs-Extreme_Obese |
5.398700E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.381400E-01 |
| Normal_Weight-vs-Obese |
7.136000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.521200E-01 |
| Extreme_Weight-vs-Obese |
4.522800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.575600E-01 |
| Obese-vs-Extreme_Obese |
9.941800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.71540000000792E-05 |
| Normal-vs-Age(41-60Yrs) |
1.837460E-04 |
| Normal-vs-Age(61-80Yrs) |
6.34819999999481E-05 |
| Normal-vs-Age(81-100Yrs) |
3.598900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.516000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.745200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.718400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.861800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.347800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.717000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.60700000000947E-05 |
| Normal-VS-Type2 PRCC |
8.230500E-04 |
| Normal-VS-KIRP CIMP |
1.53460000040795E-07 |
| Normal-VS-Unclassified PRCC |
3.009200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.582600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.62436730732907E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
1.158360E-01 |
| Type2 PRCC-VS-KIRP CIMP |
<1E-12 |
| Type2 PRCC-VS-Unclassified PRCC |
3.293000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.43449968254595E-10 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.212100E-04 |
| Normal-vs-N1 |
5.65379999999394E-05 |
| Normal-vs-N2 |
1.190010E-01 |
| N0-vs-N1 |
8.672400E-02 |
| N0-vs-N2 |
5.575600E-01 |
| N1-vs-N2 |
8.182600E-01 |
|
|
